ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL

A Contract Award Notice
by NORTHERN HEALTH AND SOCIAL CARE TRUST

Source
Find a Tender
Type
Contract ()
Duration
not specified
Value
£700K
Sector
MISCELLANEOUS
Published
14 Aug 2025
Delivery
not specified
Deadline
n/a

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

The intended contract is for the supply of Enhertu (Trastuzumab Deruxtecan) 100mg powder for solution for infusion to Northern Health and Social Care Trust for the period of three years

Award Detail

1 Novartis Pharmaceuticals (London)
  • ENHERTU (TRASTUZUMAB DERUXTECAN) 100MG POWDER FOR CONCENTRATE FOR SOLN FOR INFUSION VIAL
  • Reference: 1
  • Value: £700,000

CPV Codes

  • None found

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. **

Reference

Domains